Link's Take On The ...
Health Care: Drugs
BioTime Inc. (BTX: AMEX)
$4.02 -0.02 | -0.50%
06/19/13 - 04:03 PM ET
135.23K / 149.10K
Vol / Avg. Vol:4.00 / 4.04
Open / Prev. Close:4.00 - 4.15
Today's Range:2.67 - 5.07
52 Wk Range:24.20%
Performance YTD:TheStreet Rating:
Portfolios with BTX
- Portfolio NameUser Type
- ContributorStocks With Big Insider Buy...
- ContributorStocks Under-$10 Moving Hig...
Latest BTX Headlines from TheStreet
- July Options Now Available For BioTime (BTX) 05.20.13 | 04:05 pm
- 4 Biotech Stocks Under $10 Moving Higher 02.20.13 | 09:02 pm
Press Releases for BTX
- Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support - PR Newswire 05.23.13 | 03:05 pm
- PDL BioPharma Appoints Peter Garcia As Chief Financial Officer - PR Newswire 04.30.13 | 04:04 pm
- LifeMap Sciences, A Subsidiary Of BioTime, Announces Release Of LifeMap DiscoveryTM Version 1.1 With Enhanced Therapeutic Discovery And Commercial Utility - Business Wire 03.25.13 | 02:03 pm
- BioTime Announces Fourth Quarter And Fiscal Year End 2012 Financial Results And Recent Corporate Accomplishments - Business Wire 03.18.13 | 04:03 pm
- BioTime To Present At 25th Annual ROTH Conference - Business Wire 03.13.13 | 09:03 am
- BioTime Appoints Stephen C. Farrell To Board Of Directors - Business Wire 03.12.13 | 09:03 am
- BioTime And Romulus Agree To Accelerate Closing Date For Second Tranche Of $5 Million Financing - Business Wire 03.07.13 | 09:03 am
- (Video: Business Wire) - Business Wire 03.04.13 | 09:03 am
- LifeMap Sciences, A Subsidiary Of BioTime, Reports Its Databases Currently Utilized By An Estimated Two Million Unique Visitors Annually According To Google Analytics - Business Wire 02.11.13 | 09:02 am
- BioTime’s Subsidiary OncoCyte Corporation Provides An Update On The Development Of The Novel Pan-Cancer Diagnostic Product PanC-DxTM - Business Wire 01.31.13 | 09:01 am
Partner Headlines for BTX
- Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy - Seeking Alpha 03.28.13 | 09:03 am
- Geron Posts Narrower Loss - Analyst Blog - Zacks 10.31.12 | 09:10 am
- BioTime: Weak Pipeline Unlikely To Deliver - Seeking Alpha 07.30.12 | 09:07 am
- Earnings Report Card, Regenerative Medicine Universe Edition - Seeking Alpha 08.11.11 | 09:08 am
- Biotime Sees Its Net Loss Widen in Q2 - Seeking Alpha 08.11.11 | 09:08 am
- China Biotech Week in Review: GSK Acquires Urology Drugmaker - Seeking Alpha 12.12.10 | 09:12 am
